The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

DexCom stock was on the rise Thursday after the maker of medical technology said it had received clearance from the U.S. Food ...

The Food and Drug Administration (FDA) has cleared diabetes-management firm DexCom's (DXCM) new continuous glucose monitoring ...

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

Discussions at the Advanced Technologies & Treatments for Diabetes meeting covered CGM use in non–insulin-treated people with ...

Two endocrinologists who live with type 1 diabetes debate this issue at the Advanced Technologies & Treatments for Diabetes ...

Apple's attempts to develop a non-invasive glucose monitoring feature for Apple Watch remains "many years away" from debuting ...

A research paper by scientists at The Second Affiliated Hospital of Zhejiang University School of Medicine presented the ...

Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...